WeVote
Log In

Bill

Bill

HB 33

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATED TO CONTROLLED SUBSTANCES IN THE CITY OF NEWARK.

153rd General Assembly (2025-2026) Introduced by Mara Gorman and 4 co-sponsors

Delaware amended controlled substances laws specifically for Newark, passing with strong bipartisan support and gubernatorial approval.

Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · HB 33

Legislative bill overview

HB 33 amends Delaware's controlled substances laws specifically for Newark, though the bill's exact provisions aren't detailed in the legislative summary provided. The measure passed both chambers with substantial support and was signed into law in April 2025. The bill was sponsored by five legislators and underwent committee review in the Senate's Health & Social Services committee.

Why is this important

Changes to controlled substances laws directly affect law enforcement practices, criminal penalties, and public health responses in the affected jurisdiction. Newark, as Delaware's largest city and home to the University of Delaware, has significant populations that would be impacted by modifications to drug-related statutes. The substantial bipartisan support (37-4 in House, 19-2 in Senate) suggests broad agreement on the policy direction.

Potential points of contention

  • Lack of transparency in public summary: The specific amendments to Title 16 are not disclosed in available legislative records, making it difficult for residents to understand what changed
  • Geographic limitation to Newark: Singling out one city for different controlled substances regulations could create inconsistent enforcement across Delaware and raise equity questions
  • Health vs. enforcement approach: Depending on amendments made, the bill could shift focus between public health interventions and criminal justice responses, with different stakeholder priorities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.